MYRIAD PHARMACEUTICALS, INC. AND AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC, AS RIGHTS AGENT SHAREHOLDER RIGHTS AGREEMENT DATED AS OF JUNE , 2009Shareholder Rights Agreement • June 8th, 2009 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Shareholder Rights Agreement (“this Agreement”), dated as of June , 2009, between Myriad Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, as Rights Agent (the “Rights Agent”).
MYRIAD PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • June 8th, 2009 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Agreement sets forth the terms of the incentive stock option (“ISO”) grant made by Myriad Pharmaceuticals, Inc. (the “Company”), a Delaware corporation having a principal place of business in Salt Lake City, Utah, to the individual specified in the Notice of Grant of Stock Option and Option Agreement (the “Employee”).
SUBLEASE AGREEMENTSublease Agreement • June 8th, 2009 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Utah
change order. The cost of any change orders that are necessary to comply with applicable building codes and other laws shall be borne by Landlord, unless such change orders are necessitated only because of (1) other change orders requested by Tenant; (2) Tenant Finish Plans; (3) changes to Tenant Finish Plans; or (4) Tenant’s early occupancy to the Building prior to substantial completion of Landlord’s Work. Any change order shall be effective only when set forth on a written change order executed by Landlord, Tenant, and the Base Building General Contractor. By approving a change order, Tenant and Landlord shall agree to a delay in Substantial Completion and to the Target Date, as specified therein, if any.
EMPLOYEE MATTERS AGREEMENT by and between MYRIAD GENETICS, INC. and MYRIAD PHARMACEUTICALS, INC. Dated as of June , 2009Employee Matters Agreement • June 8th, 2009 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
EMPLOYEE MATTERS AGREEMENT (this “Agreement”), dated as of June , 2009, by and between Myriad Genetics, Inc., a Delaware corporation (“Myriad”), and Myriad Pharmaceuticals, Inc., a Delaware corporation (“MPI”). Each of Myriad and MPI is herein referred to as a “Party” and collectively, as the “Parties”.
MYRIAD PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • June 8th, 2009 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Agreement sets forth the terms of the incentive stock option (“ISO”) grant made by Myriad Pharmaceuticals, Inc. (the “Company”), a Delaware corporation having a principal place of business in Salt Lake City, Utah, to the individual specified in the Notice of Grant of Stock Option and Option Agreement of the Company (the “Employee”).
MYRIAD PHARMACEUTICALS, INC. NON-QUALIFIED OPTION AGREEMENTNon-Qualified Option Agreement • June 8th, 2009 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Agreement sets forth the terms of the Non-Qualified Option grant made by Myriad Pharmaceuticals, Inc. (the “Company”), a Delaware corporation having a principal place of business in Salt Lake City, Utah, to the individual specified in the Notice of Grant of Stock Option and Option Agreement (the “Participant”).
MYRIAD PHARMACEUTICALS, INC. NON-QUALIFIED STOCK OPTION AGREEMENTNon-Qualified Stock Option Agreement • June 8th, 2009 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Agreement sets forth the terms of the Non-Qualified Option grant made by Myriad Pharmaceuticals, Inc. (the “Company”), a Delaware corporation having a principal place of business in Salt Lake City, Utah, to the individual specified in the Notice of Grant of Stock Option and Option Agreement (the “Participant”).
RESTRICTED STOCK UNIT AGREEMENT Myriad Pharmaceuticals, Inc.Restricted Stock Unit Agreement • June 8th, 2009 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
AGREEMENT made as of the day of , 2009 (the “Grant Date”), between Myriad Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and [ ] (the “Participant”).
